- £163.65m
- £232.90m
- £308.19m
- 90
- 82
- 84
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 209 | 197 | 272 | 316 | 308 |
Cost of Revenue | |||||
Gross Profit | 54.4 | 57.2 | 80 | 81.1 | 86.8 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 197 | 177 | 246 | 302 | 282 |
Operating Profit | 11.7 | 19.5 | 26.6 | 14.8 | 26.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.46 | 9.19 | 16.3 | 10.2 | 19.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.85 | 8.7 | 14.7 | 4.31 | 15.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.85 | 8.7 | 14.7 | 4.31 | 15.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.85 | 8.7 | 14.7 | 4.31 | 15.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.013 | 0.058 | 0.181 | 0.065 | 0.137 |
Dividends per Share |